2nd May 2018 13:44
LONDON (Alliance News) - Arix Bioscience PLC on Wednesday said its investee Iterum Therapeutics has announced a proposed initial public offering on the Nasdaq Global Market.
Arix said Iterum did not give any details as to the terms and timing of the possible listing.
Arix's shares were trading at 193.30 pence each on Wednesday, up 0.2%.
Related Shares:
ARIX.L